Shionogi Hit By Surprise Japan Road Bump For Oral COVID Drug

 
• By Lisa Takagi and Ian Haydock

After months of speculation and anticipation, Shionogi’s once-daily oral antiviral for the treatment of COVID-19 has stumbled after receiving an unexpected preliminary decision on its emergency approval from an advisory committee in Japan.

Shionogi faces further discussion for approval
Shionogi's oral COVID drug hits preliminary hurdle in Japan • Source: Shutterstock

More from Japan

More from Focus On Asia